Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206335212> ?p ?o ?g. }
- W3206335212 endingPage "3585" @default.
- W3206335212 startingPage "3580" @default.
- W3206335212 abstract "Background Acne is a chronic inflammatory skin disease which involves the pilosebaceous unit. Tissue inflammation isone of the crucial mechanisms, amongst others. Of the various cytokines, leukotriene B4 (LT-B4) is the most potentleucocyte chemotactic mediator. Montelukast is an antagonist of the LT-B4 receptor. Finasteride is an antiandrogen whichspecifically inhibits the 5α-reductase enzyme. Aims This study aimed at comparing the efficacy, tolerability and safety of montelukast versus finasteride in the treatmentof moderate acne in women. Patients/Method This randomized, single-blinded, prospective trial over 12 weeks recruited 65 female subjects with moderate acne vulgaris (Global Acne Grading System Scale) for evaluation. One group (n = 30) received oral montelukast (10 mg PO daily), while the second group (n = 25) received oral finasteride (2.5 mg PO daily) in combination with topical clindamycin 2% solution. Lesion count and acne severity were evaluated at time intervals of 0 (baseline), 4, 8, and 12 weeks. Adverse effects of the drugs were noted. Results Both lesion count and severity of acne decreased significantly after treatment in both the groups as compared to the baseline. The acne severity score reached from 33.93 in time zero to 20.6 in the 12th week and 35.71 at baseline to 16.43 at the end of treatment in the Montelukast and Finasteride groups, respectively. Side effects were noted in 3 patients and 2 patients in the monteleukast and finasteride group, respectively, which were transient and non-serious in nature proving the satisfactory tolerability and safety of these two drugs. Conclusion The results of this study show that both montelukast and finasteride have good efficacy in the treatment of acne. Finasteride has more efficacy than montelukast for treating moderate acne in normo-androgenic women." @default.
- W3206335212 created "2021-10-25" @default.
- W3206335212 creator A5000235038 @default.
- W3206335212 creator A5009617732 @default.
- W3206335212 creator A5033544451 @default.
- W3206335212 creator A5037290387 @default.
- W3206335212 creator A5042994855 @default.
- W3206335212 creator A5053641355 @default.
- W3206335212 creator A5060612968 @default.
- W3206335212 creator A5066442707 @default.
- W3206335212 date "2021-10-14" @default.
- W3206335212 modified "2023-10-18" @default.
- W3206335212 title "Efficacy, tolerability, and safety of montelukast versus finasteride for the treatment of moderate acne in women: A prospective, randomized, single‐blinded, active‐controlled trial" @default.
- W3206335212 cites W1612870705 @default.
- W3206335212 cites W1965659086 @default.
- W3206335212 cites W1971883262 @default.
- W3206335212 cites W1992981307 @default.
- W3206335212 cites W1993768080 @default.
- W3206335212 cites W2015142872 @default.
- W3206335212 cites W2017584016 @default.
- W3206335212 cites W2045360813 @default.
- W3206335212 cites W2055292191 @default.
- W3206335212 cites W2062768474 @default.
- W3206335212 cites W2073101615 @default.
- W3206335212 cites W2082030932 @default.
- W3206335212 cites W2093482549 @default.
- W3206335212 cites W2121063030 @default.
- W3206335212 cites W2149521457 @default.
- W3206335212 cites W2158599779 @default.
- W3206335212 cites W2244215849 @default.
- W3206335212 cites W2399714615 @default.
- W3206335212 cites W2401783755 @default.
- W3206335212 cites W2664951736 @default.
- W3206335212 cites W2807465786 @default.
- W3206335212 cites W2923845314 @default.
- W3206335212 cites W2967784243 @default.
- W3206335212 cites W4256214116 @default.
- W3206335212 doi "https://doi.org/10.1111/jocd.14462" @default.
- W3206335212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34648685" @default.
- W3206335212 hasPublicationYear "2021" @default.
- W3206335212 type Work @default.
- W3206335212 sameAs 3206335212 @default.
- W3206335212 citedByCount "3" @default.
- W3206335212 countsByYear W32063352122022 @default.
- W3206335212 countsByYear W32063352122023 @default.
- W3206335212 crossrefType "journal-article" @default.
- W3206335212 hasAuthorship W3206335212A5000235038 @default.
- W3206335212 hasAuthorship W3206335212A5009617732 @default.
- W3206335212 hasAuthorship W3206335212A5033544451 @default.
- W3206335212 hasAuthorship W3206335212A5037290387 @default.
- W3206335212 hasAuthorship W3206335212A5042994855 @default.
- W3206335212 hasAuthorship W3206335212A5053641355 @default.
- W3206335212 hasAuthorship W3206335212A5060612968 @default.
- W3206335212 hasAuthorship W3206335212A5066442707 @default.
- W3206335212 hasBestOaLocation W32063352121 @default.
- W3206335212 hasConcept C121608353 @default.
- W3206335212 hasConcept C126322002 @default.
- W3206335212 hasConcept C16005928 @default.
- W3206335212 hasConcept C168563851 @default.
- W3206335212 hasConcept C197934379 @default.
- W3206335212 hasConcept C204243189 @default.
- W3206335212 hasConcept C2775874879 @default.
- W3206335212 hasConcept C2776042228 @default.
- W3206335212 hasConcept C2776235491 @default.
- W3206335212 hasConcept C2776322731 @default.
- W3206335212 hasConcept C2777673923 @default.
- W3206335212 hasConcept C2777911890 @default.
- W3206335212 hasConcept C2778375690 @default.
- W3206335212 hasConcept C2779322244 @default.
- W3206335212 hasConcept C71315377 @default.
- W3206335212 hasConcept C71924100 @default.
- W3206335212 hasConcept C90924648 @default.
- W3206335212 hasConceptScore W3206335212C121608353 @default.
- W3206335212 hasConceptScore W3206335212C126322002 @default.
- W3206335212 hasConceptScore W3206335212C16005928 @default.
- W3206335212 hasConceptScore W3206335212C168563851 @default.
- W3206335212 hasConceptScore W3206335212C197934379 @default.
- W3206335212 hasConceptScore W3206335212C204243189 @default.
- W3206335212 hasConceptScore W3206335212C2775874879 @default.
- W3206335212 hasConceptScore W3206335212C2776042228 @default.
- W3206335212 hasConceptScore W3206335212C2776235491 @default.
- W3206335212 hasConceptScore W3206335212C2776322731 @default.
- W3206335212 hasConceptScore W3206335212C2777673923 @default.
- W3206335212 hasConceptScore W3206335212C2777911890 @default.
- W3206335212 hasConceptScore W3206335212C2778375690 @default.
- W3206335212 hasConceptScore W3206335212C2779322244 @default.
- W3206335212 hasConceptScore W3206335212C71315377 @default.
- W3206335212 hasConceptScore W3206335212C71924100 @default.
- W3206335212 hasConceptScore W3206335212C90924648 @default.
- W3206335212 hasIssue "11" @default.
- W3206335212 hasLocation W32063352121 @default.
- W3206335212 hasLocation W32063352122 @default.
- W3206335212 hasOpenAccess W3206335212 @default.
- W3206335212 hasPrimaryLocation W32063352121 @default.
- W3206335212 hasRelatedWork W163082982 @default.
- W3206335212 hasRelatedWork W171042198 @default.
- W3206335212 hasRelatedWork W2025083782 @default.
- W3206335212 hasRelatedWork W2034845948 @default.